Properties of Filaggrin Associating with Skin Barrier Structure in Moisture Retention

doi:10.21127/yaoyimr20170005

Medicine Research ›› 2017, Vol. 1 ›› Issue (1): 16-19.DOI: 10.21127/yaoyimr20170005

收稿日期:2017-07-28 接受日期:2017-08-04 出版日期:2017-08-08 发布日期:2017-08-07
基金资助:

Properties of Filaggrin Associating with Skin Barrier Structure in Moisture Retention

Yang Jing^a^b^†,Wang Shujun^b^†,Yang Weijie^a,Yu Xiaowei^c,Bao Bin^a^d^*

^aDepartment of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University,Shanghai 201306, China
^b Co-Innovation Center of Jiangsu Marine Bio-Industry Technology, Huaihai Institute of Technology,Lianyungang, Jiangsu 222005, China
^cDepartment of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Shanghai 200233, China;
^d Shanghai Engineering Research Center of Aquatic-Product Processing & Preservation, Shanghai 201306, China;

Received:2017-07-28 Accepted:2017-08-04 Online:2017-08-08 Published:2017-08-07
Contact: Yang Jing,Wang Shujun,Bao Bin
Supported by:

摘要/Abstract

摘要：

关键词:

Abstract:

The skin barrier is regulated by the stratum corneum and the tight junction located at the lamellar layer. Skin barrier can maintain the body’s moisture, prevent pathogens and allergens. Atopic dermatitis is caused by changes in the skin barrier associating with skin coloring. The main function of filaggrin is to maintain skin moisture. The level of filaggrin and its degradation products is affected not only by the genotype of filaggrin, but also by the inflammatory and exogenous stress factors. Regardless of the state of mutations in the filamentous protein, filaggrin deficiency was observed in patients with atopic dermatitis, indicating that the removal of polyphenol was a key factor in the pathogenesis of the skin disease. In this paper, we reviewed the function and morphological effects of filaggrin and its metabolites in the pathogenesis of atopic dermatitis. Filaggrin is considered as one of the most important proteins in the skin barrier.

Key words: filaggrin, keratinocyte, skin barrier, transepidermal water loss, cytokines

中图分类号:

. [J]. Medicine Research, 2017, 1(1): 16-19.

Yang Jing, Wang Shujun, Yang Weijie, Yu Xiaowei, Bao Bin. Properties of Filaggrin Associating with Skin Barrier Structure in Moisture Retention[J]. Medicine Research, 2017, 1(1): 16-19.

参考文献

[1]	Tomohisa H. Dermatol. Sin. 2014, 32, 200.
[2]	Joseph C.; Jerry G.; Daniel G. H.; Cristin G. P. P.; Rod D.; Marc D. J.; Edmund, J. C. BMC Systems Biol.2015,9, 1.
[3]	Kezic S.; O’Regan G. M.; Yau N.; Sandilands A.; Chen H.; Campbell L. E.; Kroboth K.; Watson R.; Rowland M.; Irwin McLean W. H.; Irvine A. D. Allergy 2011, 66, 934
[4]	Laurence P.; Julie H.; Chiung-Yueh, H.; Stéfana, B.; Catherine, J. D.; Marie-Claire, M.; Britta, H.; Elke, R.; Stefan, W.; Anne-Marie, S.; Guy, S.; Carle, P.; Michel, S. J. Allergy Clin. Immunol. 2013, 131, 1094.
[5]	Harding C. R.; Scott, I. R. J. Mol. Biol. 1983, 170, 651.
[6]	Howell M. D.; Kim B. E.; Gao P.; Grant A. V.; Boguniewicz M.; DeBenedetto, A.; Schneider, L.; Beck, L. A.; Barnes, K. C.; Leung, D. Y.J. Allergy Clin. Immunol. 2009, 124, 7.
[7]	Elias P. M.; Hatano Y.; Williams M. L. J. Allergy Clin. Immunol. 2008, 121, 1337.
[8]	Anna D. B. J. Allergy Clin. Immunol.2011,127, 773.
[9]	Shi V. Y.; Foolad, N.; Ornelas, J. N.; Hassoun, L. A.; Monico, G.; Takeda, N.; Saric, S.; Prakash, N.; Eichenfield, L. F.; Sivamani, R. K. Br. J. Dermatol. 2016, 175, 212.
[10]	Elias,P. M. Biochim. Biophys. Acta 2014, 1841, 323.
[11]	Kubo A.; Nagao K.; Amagai M. J. Clin. Invest. 2012,122, 440.
[12]	Carien M. N. J. Investig. Dermatol. 2007, 127, 2525.
[13]	Flohr C.; England K.; Radulovic S.; McLean W. H. I.; Campbell L. E.; Barker J.; Perkin M.; Lack, G. Br. J. Dermatol. 2010, 163, 1333.
[14]	Robert G.; Peter M. E.; Debra C.; Tzu-Kai L.; Johanna M. B.; Jean-Pierre H.; Richard B. P.; Philip, F. Am. J. Pathol. 2011,178, 2252.
[15]	Perusquía-Ortiz, A. M.; Oji, V.; Sauerland, M.C.; Tarinski, T.; Zaraeva, I.; Seller, N.; Metze, D.; Aufenvenne, K.; Hausser, I.; Traupe, H. J. Eur. Acad. Dermatol. Venereol. 2013, 27, 1552.
[16]	Imokawa,G.J.Dermatol. Sci. 2009, 55, 1.
[17]	Jean-Pierre, H.; Fredrik, W.; Matthias, S.; Debra, C.; Willy, L.; Arumugam, J.; Evi H.; Theodora, M. M.; Goran, L.; Maria, B.; Torbjorn, E.; Diane, R.; Gary, L. C.; Kenneth, R. F.; Mary, L. W.; Peter, M. E. J. Investig. Dermatol. 2006, 126, 1609.
[18]	Nylander-Lundqvist E.; Egelrud, T. Acta Derm. Venereol.1997,77, 203.
[19]	Harding C. R.; Aho S.; Bosko C. A. Int. J. Cosmet. Sci. 2013,35, 412.
[20]	Maeve A. M.;Alan D. I.Jacobs J. Allergy Immunol. 2013, 131, 280.
[21]	Ian R. S.; Clive, R. H. Dev. Biol.1986, 115, 84.
[22]	Bernerd F.; Asselineau D. Dev. Biol. 1997, 183, 123.
[23]	Gerritsen M. J.; Pelt J. P.; Pc, V. D. K. Acta Derm. Venereol. 1996, 76, 6.
[24]	Eung-Ho C.; Barbara E. B.; Debra C.; Sandra C.; Mao-Qiang M.; Peter M. E.; Kenneth, R. F. J. Investig. Dermatol. 2005, 124, 587.
[25]	Swinkels O. Q.; Prins M.;Birker L. W.; Gerritsen M. J.; Valk P. G.; Kerkhof P. C. Skin Pharmacol Appl. Skin Physiol. 2002,15, 262.
[26]	Hamm-Ming, S.; Chang-Long, T.; Kou-Wha, K.; Hsin-Su Y.; Chee-Yin, C. J. Dermatol. 1991, 18, 454.
[27]	Thyssen J. P.; Godoy-Gijon E.; Elias, P. M. Br. J. Dermatol. 2013, 168, 1155.
[28]	Ziyab A. H.; Karmaus W.; Holloway J. W.; Zhang H.; Ewart S.; Arshad, S. H. J. Eur. Acad. Dermatol Venereol. 2013, 27, 420.
[29]	Carson C. G.;Rasmussen M. A.;Thyssen J. P.; Menné T.; Bisgaard H. PLoS ONE 2012, 7, 1.
[30]	Hans T.; Magnus L.; Berit, B. J. Investig. Dermatol. 2008, 128, 1212.
[31]	Takai T. Allergol.Int.2012, 61, 3.
[32]	Gao P. S.; Rafaels N. M.; Hand T.; Murray T.; Boguniewicz M.; Hata T.; Schneider L.; Hanifin J. M.; Gallo R. L.; Gao L.; Beaty T. H.; Beck L. A.; Barnes K. C.; Leung D. Y. J. Allergy Clin. Immunol. 2009, 124, 1.
[33]	Pellerin L.; Henry J.; Hsu C. Y. J. Allergy Clin. Immunol. 2013, 131, 1094.
[34]	Thyssen J. P.; Kezic, S. J. Allergy Clin. Immunol. 2014, 134, 792.
[35]	Kubo A.; Nagao K.; Amagai, M. J. Clin. Invest. 2012, 122, 440.
[36]	Brown S. J.; Mclean, W. H. J. Investig. Dermatol.2012, 132, 751.
[37]	Brown S. J.; Kroboth K.; Sandilands, A. J. Investig. Dermatol. 2012, 132, 98.
[38]	Bogaard E. H. V. D.; Bergboer J. G. M.; Vonk-Bergers, M. J. Clin. Invest. 2013, 123, 917.
[39]	Gao P. S.; Rafaels N. M.; Hand, T. J. Allergy Clin. Immunol. 2009, 124, 1.

Properties of Filaggrin Associating with Skin Barrier Structure in Moisture Retention

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	Zhao Wang, Filipe Olim, Jingjing Sun, Ana Rute Neves, Fátima Mendes, Helena Tomás, and Ruilong Sheng. Prodrug Systems (II): A Perspective of Polymer-Based Doxorubicin Prodrug Systems towards Chemotherapy[J]. Medicine Research, 2021, 5(1): 200023-200023.
[2]	Hao Wang, Ji-Lei Liang, Qing-Ming He, Guo-Hai Zhou, Cun-Fu Li, Ping-He Wei, and Hao-Yan Dong. Flavonoids, Phenylethanoids and Phenylpropanoids from Rhodiola rosea L. and Their Lipid-Lowering Activities on Receptor 5-HT_2A[J]. Medicine Research, 2020, 4(4): 200018-200018.
[3]	. Contents: Med. Res. 4/2020 [J]. Medicine Research, 2020, 4(4): 0-0.
[4]	. [J]. Medicine Research, 2020, 4(1-2): 209001-209001.
[5]	. Contents: Med. Res. 3/2019[J]. Medicine Research, 2019, 3(4): 0-0.
[6]	. 2019 Nobel Prize in Physiology or Medicine[J]. Medicine Research, 2019, 3(4): 196002-.
[7]	Chaoyan Zhang. Chaoyan Zhang[J]. Medicine Research, 2019, 3(4): 198003-.
[8]	. Contents: Med. Res. 3/2019[J]. Medicine Research, 2019, 3(3): 0-.
[9]	. Interview with Professor Nenling Zhang[J]. Medicine Research, 2019, 3(2): 198002-.
[10]	. Contents: Med. Res. 2/2019 [J]. Medicine Research, 2019, 3(2): 0-.
[11]	. Xplorer Awards in Life Sciences[J]. Medicine Research, 2019, 3(2): 20196001-.
[12]	Jun Zhu, Jiejun Cheng, Juan Zhou, Gang Huang, Dannong He. Surface Modification on Ultra High Molecular Weight Polyethylene Scaffold with Silk Fibroin[J]. Medicine Research, 2019, 3(2): 190006-.
[13]	Jingjuan Li, Fucai Ren, Jiangmiao Hu. Progress of Picrotoxane Type Alkaloids in Dendrobium[J]. Medicine Research, 2019, 3(2): 190007-.
[14]	Medicine Research. Contents: Med. Res. 3/2018[J]. Medicine Research, 2018, 2(3): 0-0.
[15]	. Contents: Med. Res. 2/2018[J]. Medicine Research, 2018, 2(2): 180000-.